Dr. James Rucker is a consultant psychiatrist currently leading the psychedelic trials group at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. He is currently leading a randomised control trial invesitgating the safety and efficacy of the active component of magic mushrooms (psilocybin) for use in treatment resistant depression. 

Interviewed by Dr. Alex Curmi - Give feedback here - thinkingmindpodcast@gmail.com -  Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

SUPPORT: buymeacoffee.com/thinkingmind